2-232484900-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004826.4(ECEL1):​c.967-7C>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0124 in 1,613,230 control chromosomes in the GnomAD database, including 155 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0088 ( 12 hom., cov: 34)
Exomes 𝑓: 0.013 ( 143 hom. )

Consequence

ECEL1
NM_004826.4 splice_region, intron

Scores

2
Splicing: ADA: 0.01538
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.0240

Publications

2 publications found
Variant links:
Genes affected
ECEL1 (HGNC:3147): (endothelin converting enzyme like 1) This gene encodes a member of the M13 family of endopeptidases. Members of this family are zinc-containing type II integral-membrane proteins that are important regulators of neuropeptide and peptide hormone activity. Mutations in this gene are associated with autosomal recessive distal arthrogryposis, type 5D. This gene has multiple pseudogenes on chromosome 2. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]
ECEL1 Gene-Disease associations (from GenCC):
  • distal arthrogryposis type 5D
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 2-232484900-G-C is Benign according to our data. Variant chr2-232484900-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 128956.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0088 (1341/152318) while in subpopulation NFE AF = 0.0142 (964/68016). AF 95% confidence interval is 0.0134. There are 12 homozygotes in GnomAd4. There are 643 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 12 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ECEL1NM_004826.4 linkc.967-7C>G splice_region_variant, intron_variant Intron 4 of 17 ENST00000304546.6 NP_004817.2
ECEL1NM_001290787.2 linkc.967-7C>G splice_region_variant, intron_variant Intron 4 of 17 NP_001277716.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ECEL1ENST00000304546.6 linkc.967-7C>G splice_region_variant, intron_variant Intron 4 of 17 1 NM_004826.4 ENSP00000302051.1
ECEL1ENST00000409941.1 linkc.967-7C>G splice_region_variant, intron_variant Intron 3 of 16 1 ENSP00000386333.1
ECEL1ENST00000482346.1 linkn.1278-7C>G splice_region_variant, intron_variant Intron 3 of 16 2

Frequencies

GnomAD3 genomes
AF:
0.00880
AC:
1340
AN:
152200
Hom.:
12
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00246
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00628
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.0147
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0142
Gnomad OTH
AF:
0.00334
GnomAD2 exomes
AF:
0.00876
AC:
2196
AN:
250802
AF XY:
0.00865
show subpopulations
Gnomad AFR exome
AF:
0.00222
Gnomad AMR exome
AF:
0.00443
Gnomad ASJ exome
AF:
0.000794
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.0152
Gnomad NFE exome
AF:
0.0135
Gnomad OTH exome
AF:
0.0127
GnomAD4 exome
AF:
0.0128
AC:
18701
AN:
1460912
Hom.:
143
Cov.:
60
AF XY:
0.0124
AC XY:
9006
AN XY:
726782
show subpopulations
African (AFR)
AF:
0.00194
AC:
65
AN:
33478
American (AMR)
AF:
0.00463
AC:
207
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.000995
AC:
26
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00232
AC:
200
AN:
86250
European-Finnish (FIN)
AF:
0.0148
AC:
780
AN:
52664
Middle Eastern (MID)
AF:
0.00243
AC:
14
AN:
5768
European-Non Finnish (NFE)
AF:
0.0151
AC:
16801
AN:
1111820
Other (OTH)
AF:
0.0101
AC:
607
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
1068
2136
3203
4271
5339
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
624
1248
1872
2496
3120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00880
AC:
1341
AN:
152318
Hom.:
12
Cov.:
34
AF XY:
0.00863
AC XY:
643
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.00245
AC:
102
AN:
41562
American (AMR)
AF:
0.00627
AC:
96
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5184
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4830
European-Finnish (FIN)
AF:
0.0147
AC:
156
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0142
AC:
964
AN:
68016
Other (OTH)
AF:
0.00331
AC:
7
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
73
146
220
293
366
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0105
Hom.:
3
Bravo
AF:
0.00829
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.0116
EpiControl
AF:
0.0116

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:6
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jan 04, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 01, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ECEL1: BP4, BS1, BS2

not specified Benign:3
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Apr 06, 2018
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
6.1
DANN
Benign
0.42
PhyloP100
-0.024
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.015
dbscSNV1_RF
Benign
0.12
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76735188; hg19: chr2-233349610; API